The congress on june 11-12, 2026, provides an up-to-date overview ofsoft tissue and bone tumors in light of the who 2026 classification.key sessions will cover emerging tumor entities, recently describedcutaneous and visceral neoplasms, and diagnostic mimickers, withinsights on the latest immunohistochemistry and moleculartechniques. Case-based slide seminars encourage interactive learningand practical application. This program aims to enhance diagnosticaccuracy, foster expert discussion, and emphasize the clinicalrelevance of precise tumor classification.